Status: current, Primitive. Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4544736012 | Cabotegravir (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4544737015 | Cabotegravir | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cabotegravir | Is a | Pyridine | true | Inferred relationship | Some | ||
| Cabotegravir | Is a | Integrase strand transfer inhibitor | true | Inferred relationship | Some | ||
| Cabotegravir | Has disposition | Integrase strand transfer inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cabotegravir 200 mg/mL prolonged-release suspension for injection | Has precise active ingredient | True | Cabotegravir | Inferred relationship | Some | 1 |
| Cabotegravir 200 mg/mL prolonged-release suspension for injection | Has BoSS | True | Cabotegravir | Inferred relationship | Some | 1 |
| Cabotegravir-containing product | Has active ingredient | True | Cabotegravir | Inferred relationship | Some | 1 |
| Cabotegravir only product | Has active ingredient | True | Cabotegravir | Inferred relationship | Some | 1 |
| Cabotegravir-containing product in parenteral dose form | Has active ingredient | True | Cabotegravir | Inferred relationship | Some | 1 |
| Cabotegravir only product in parenteral dose form | Has active ingredient | True | Cabotegravir | Inferred relationship | Some | 1 |
| Cabotegravir sodium | Is modification of | True | Cabotegravir | Inferred relationship | Some |
Reference Sets
Substance foundation reference set
FHIR